331 related articles for article (PubMed ID: 32961040)
1. Viral pandemic preparedness: A pluripotent stem cell-based machine-learning platform for simulating SARS-CoV-2 infection to enable drug discovery and repurposing.
Esmail S; Danter W
Stem Cells Transl Med; 2021 Feb; 10(2):239-250. PubMed ID: 32961040
[TBL] [Abstract][Full Text] [Related]
2. Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing.
Glebov OO
FEBS J; 2020 Sep; 287(17):3664-3671. PubMed ID: 32428379
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery.
Mulay A; Konda B; Garcia G; Yao C; Beil S; Villalba JM; Koziol C; Sen C; Purkayastha A; Kolls JK; Pociask DA; Pessina P; de Aja JS; Garcia-de-Alba C; Kim CF; Gomperts B; Arumugaswami V; Stripp BR
Cell Rep; 2021 May; 35(5):109055. PubMed ID: 33905739
[TBL] [Abstract][Full Text] [Related]
4. COVID-19: Discovery, diagnostics and drug development.
Asselah T; Durantel D; Pasmant E; Lau G; Schinazi RF
J Hepatol; 2021 Jan; 74(1):168-184. PubMed ID: 33038433
[TBL] [Abstract][Full Text] [Related]
5. Lung organoid simulations for modelling and predicting the effect of mutations on SARS-CoV-2 infectivity.
Esmail S; Danter WR
Comput Struct Biotechnol J; 2021; 19():1701-1712. PubMed ID: 33815693
[TBL] [Abstract][Full Text] [Related]
6. Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates.
Serafim MSM; Gertrudes JC; Costa DMA; Oliveira PR; Maltarollo VG; Honorio KM
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33624754
[TBL] [Abstract][Full Text] [Related]
7. Fighting COVID-19 with Artificial Intelligence.
Monteleone S; Kellici TF; Southey M; Bodkin MJ; Heifetz A
Methods Mol Biol; 2022; 2390():103-112. PubMed ID: 34731465
[TBL] [Abstract][Full Text] [Related]
8. Repurposing therapeutics for COVID-19: Rapid prediction of commercially available drugs through machine learning and docking.
Mohapatra S; Nath P; Chatterjee M; Das N; Kalita D; Roy P; Satapathi S
PLoS One; 2020; 15(11):e0241543. PubMed ID: 33180803
[TBL] [Abstract][Full Text] [Related]
9. Repurposing anticancer drugs for the management of COVID-19.
El Bairi K; Trapani D; Petrillo A; Le Page C; Zbakh H; Daniele B; Belbaraka R; Curigliano G; Afqir S
Eur J Cancer; 2020 Dec; 141():40-61. PubMed ID: 33125946
[TBL] [Abstract][Full Text] [Related]
10. Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight.
Begum F; Srivastava AK; Ray U
Biochem Biophys Res Commun; 2021 Sep; 571():26-31. PubMed ID: 34303192
[TBL] [Abstract][Full Text] [Related]
11. Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
Kumar P; Sah AK; Tripathi G; Kashyap A; Tripathi A; Rao R; Mishra PC; Mallick K; Husain A; Kashyap MK
Mol Cell Biochem; 2021 Feb; 476(2):553-574. PubMed ID: 33029696
[TBL] [Abstract][Full Text] [Related]
12. Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study.
Baby K; Maity S; Mehta CH; Suresh A; Nayak UY; Nayak Y
Arch Med Res; 2021 Jan; 52(1):38-47. PubMed ID: 32962867
[TBL] [Abstract][Full Text] [Related]
13. COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
Aljabali AAA; Bakshi HA; Satija S; Metha M; Prasher P; Ennab RM; Chellappan DK; Gupta G; Negi P; Goyal R; Sharma A; Mishra V; Dureja H; Dua K; Tambuwala MM
Pharm Nanotechnol; 2020; 8(4):323-353. PubMed ID: 32811406
[TBL] [Abstract][Full Text] [Related]
14. Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis.
Adhami M; Sadeghi B; Rezapour A; Haghdoost AA; MotieGhader H
BMC Biotechnol; 2021 Mar; 21(1):22. PubMed ID: 33711981
[TBL] [Abstract][Full Text] [Related]
15. Staying Ahead of the Game: How SARS-CoV-2 has Accelerated the Application of Machine Learning in Pandemic Management.
Williams AH; Zhan CG
BioDrugs; 2023 Sep; 37(5):649-674. PubMed ID: 37464099
[TBL] [Abstract][Full Text] [Related]
16. SperoPredictor: An Integrated Machine Learning and Molecular Docking-Based Drug Repurposing Framework With Use Case of COVID-19.
Ahmed F; Lee JW; Samantasinghar A; Kim YS; Kim KH; Kang IS; Memon FH; Lim JH; Choi KH
Front Public Health; 2022; 10():902123. PubMed ID: 35784208
[TBL] [Abstract][Full Text] [Related]
17. Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium.
Gupta RK; Nwachuku EL; Zusman BE; Jha RM; Puccio AM
PLoS One; 2021; 16(9):e0257784. PubMed ID: 34582497
[TBL] [Abstract][Full Text] [Related]
18. Machine Learning Applications in Drug Repurposing.
Yang F; Zhang Q; Ji X; Zhang Y; Li W; Peng S; Xue F
Interdiscip Sci; 2022 Mar; 14(1):15-21. PubMed ID: 35066811
[TBL] [Abstract][Full Text] [Related]
19. Step toward repurposing drug discovery for COVID-19 therapeutics through in silico approach.
Marak BN; Dowarah J; Khiangte L; Singh VP
Drug Dev Res; 2021 May; 82(3):374-392. PubMed ID: 33170521
[TBL] [Abstract][Full Text] [Related]
20. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
Das AB
BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
